Journal article
Potential roles of hyaluronic acid in in vivo CAR T cell reprogramming for cancer immunotherapy
Nanoscale, Vol.14(48), pp.17821-17840
12/15/2022
DOI: 10.1039/D2NR05949E
PMID: 36472072
Abstract
Chimeric antigen receptor (CAR) T cell therapy has recently shown unprecedented clinical efficacy for cancer treatment, particularly of hematological malignancies. However, the complex manufacturing processes that involve ex vivo genetic modification of autologous T cells limits its therapeutic application. CAR T cells generated in vivo provide a valid alternative immunotherapy, “off-the-shelf”, for cancer treatment. This approach requires carriers for the delivery of CAR-encoding constructs, which are plasmid DNA or messenger RNA, to T cells for CAR expression to help eradicate the tumor. As such, there are a growing number of studies reporting gene delivery systems for in vivo CAR T cell therapy based on viral vectors and polymeric nanoparticles. Hyaluronic acid (HA) is a natural biopolymer that can serve for gene delivery, because of its inherent properties of cell recognition and internalization, as well as its biodegradability, biocompatibility, and presence of functional groups for the chemical conjugation of targeting ligands. In this review, the potential of HA in the delivery of CAR constructs is discussed on the basis of previous experience of HA-based nanoparticles for gene therapy. Furthermore, current studies on CAR carriers for in vivo -generated CAR T cells are included, giving an idea of a rational design of HA-based systems for the more efficient delivery of CAR to circulating T cells.
Details
- Title: Subtitle
- Potential roles of hyaluronic acid in in vivo CAR T cell reprogramming for cancer immunotherapy
- Creators
- Chavee Laomeephol - Chulalongkorn UniversitySudartip Areecheewakul - Chulalongkorn UniversitySupannikar Tawinwung - Chulalongkorn UniversityKoramit Suppipat - Chulalongkorn UniversityPreedakorn Chunhacha - Chulalongkorn UniversityNuno M. Neves - University of MinhoJittima Amie Luckanagul - Chulalongkorn University
- Resource Type
- Journal article
- Publication Details
- Nanoscale, Vol.14(48), pp.17821-17840
- DOI
- 10.1039/D2NR05949E
- PMID
- 36472072
- ISSN
- 2040-3364
- eISSN
- 2040-3372
- Language
- English
- Date published
- 12/15/2022
- Academic Unit
- Pharmaceutical Sciences and Experimental Therapeutics
- Record Identifier
- 9984629157502771
Metrics
3 Record Views